Country Reports

Country Report: United Arab Emirates

March 01, 2020

Pharmaceutical Executive

With an estimated annual growth rate of 10%, the Middle East is now consistently outpacing traditionally sought-after “pharmerging” heavyweights such as China and Brazil. The United Arab Emirates is at the center of this newfound momentum-asserting its own credentials as a prospective destination for big-ticket foreign investment in healthcare.

Country Report: Portugal

August 01, 2018

Pharmaceutical Executive

Behind an economic revival in Portugal, including healthcare spending growth, the nation’s life sciences sector is benefiting as well, with Portugal diverging from the European averages to show an increase in R&D and innovation.

Country Report: India

July 01, 2018

Pharmaceutical Executive

The Indian pharmaceutical industry is traditionally known as a global powerhouse for the production of bulk drugs and generics, but less heralded is the growth India has made on the pharma world stage in several other areas, including biotechnology and R&D.

Country Report: Canada

May 01, 2018

Pharmaceutical Executive

Away from the glare of publicity, a tranche of bold reforms in Canada, aimed at harmonizing the national health system and delivering value for money, are fast nearing completion.

Pharmaceutical Executive

Country Report: Poland

April 01, 2018

Still motivated by its challenging, underdog past, Poland has strengthened its economic engine in Europe, where the nation’s pharmaceutical sector is increasingly pursuing enlightened approaches in areas such as market access and evidence-based decision-making.

Pharmaceutical Executive

Country Report: India

March 01, 2018

The global importance of the Indian pharmaceutical industry and the affordable generic drugs it produces is indisputable. But despite its evolving international role, India’s domestic healthcare system remains underperforming and undercapitalized.

Pharmaceutical Executive

Country Report: Brazil

February 01, 2018

In its ambition to further strengthen the nation’s relationship with the global industry, Brazil holds a valuable, eye-catching asset: the dynamism of its huge pharmaceutical market, the sixth-largest in the world.

Pharmaceutical Executive

Country Report: Switzerland

January 01, 2018

Three pivotal developments that occurred in 2017 illustrate the growing relevance and influence of the Swiss pharmaceutical and life sciences industry on the world stage. Companies in Switzerland are also playing innovative roles in reshaping the pharma value chain and contemporary paradigm of healthcare provision.

Pharmaceutical Executive

Country Report: Canada

December 01, 2017

Despite having the tenth-largest pharma market in the world and being the birthplace of medical breakthroughs, from insulin to stem cells, Canada seems to be punching below its weight when it comes to health innovation. There are signs, however, that things may be changing as the nation looks to bulk back up.

Pharmaceutical Executive

Country Report: Austria

November 01, 2017

As the global reputation of neighboring pharma giants Switzerland and Germany continues to soar, Austria too is on the move, with the ambition of becoming a real driver and shaper of global medical innovation rather than merely just a link in the chain.

Pharmaceutical Executive

Country Report: Colombia

October 01, 2017

Emerging as a bastion of peace, stability, and resilience in a region increasingly beset by political turbulence and economic stagnation, Colombia has been steadily reinventing itself as a Latin American pioneer and pacesetter, including in the world of healthcare.

Pharmaceutical Executive

Country Report: Taiwan

June 01, 2017

Although the local pharma and biotech sectors in Taiwan have yet to emulate the success story of its semiconductor industry, companies in the life sciences have reached a solid level of maturity, notably driven by the substantial investments injected by Taiwan’s successive governments over the past two decades.

Pharmaceutical Executive

Country Report: Switzerland

May 01, 2017

Home to some of the world’s most important international health institutions and some big pharma players as well, Switzerland lays claim as a healthcare and life sciences powerhouse. Navigating its pharmaceutical market terrain, however, does not come without its challenges.

Pharmaceutical Executive

Country Report: Greece

March 31, 2017

Is the Greek pharmaceuticals and healthcare sector, once a strong bridge between Europe and the East, on the mend after suffering the recent ravages of the global financial crisis and subsequent austerity policies?

Pharmaceutical Executive

Country Report: Singapore

February 01, 2017

Despite serving as a regional hub for numerous leading global healthcare and life sciences companies-while simultaneously straddling the frontier of biomedical advancement and innovation-Singapore is reinventing itself yet again and spearheading a new model of Asian healthcare.

Pharmaceutical Executive

Country Report: Philippines

January 01, 2017

This sponsored supplement was produced by Focus ReportsProject Publisher: Mariuca GeorgescuProject Director: Carla Verdera MateuCoordinators: Brandon Mourich & Julija LukaityteProject Assistants: Zoë BerginSenior Editor: Louis HaynesEditor: Patrick Burton

Pharmaceutical Executive

Country Report: Mexico

December 01, 2016

In a regional context marked by chronic instability and turmoil in strategic Latin American economies such as Brazil and Venezuela, Mexico has continually strengthened its positioning as a destination of choice for the global pharmaceutical industry.

Pharmaceutical Executive

Country Report: Switzerland

November 01, 2016

Switzerland’s formidable pedigree as a pharmaceuticals powerhouse and hotbed of scientific innovation is often overlooked. But indeed these elements serve as major linchpins of the Swiss national economy, as the country continues to punch above its weight on the global stage for health affairs and medical-science advancement.